Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes
Moran, A. (PI)
INDIANA UNIVERSITY, BREAKTHROUGH T1D
11/1/24 → 10/31/25
Project: Research project
-
A Phase 1 open-label, single ascending dose study of ABA-201 in participants with new onset type 1 diabetes (Stage 3)
Moran, A. (PI)
10/22/24 → 10/20/35
Project: Research project
-
Mechanistic Etiologies Underlying the Impact of Verapamil to Preserve Beta Cell Function in Type 1 diabetes
Moran, A. (PI)
9/1/24 → 8/31/26
Project: Research project
-
Diabetes in African Youth: Improving Glucose Time-In-Range (DAYTime)
Moran, A. (PI)
5/1/24 → 12/31/26
Project: Research project
-
Exogenous insulin does not reduce protein catabolism in pre-diabetic cystic fibrosis patients: A randomized clinical trial
Schiavon, M., Cobelli, C., Nair, K. S., Klaus, K., Toffolo, G., Zhang, L. & Moran, A., Jan 2025, In: Journal of Cystic Fibrosis. 24, 1, p. 57-65 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Personalized Hemoglobin A1c Shows Better Correlation with Mean Glucose than Laboratory Hemoglobin A1c in Ugandan Youth with Type 1 Diabetes, but Mean Glucose Is Not Clinically Useful in This Population Due to Extreme Glucose Variability
Piloya-Were, T., Nyangabayaki, C., Dunn, T. C., Malinga, D., Nambooze, J., Pappenfus, E., Zhang, L., Bindal, A., Beasley, S., Sunni, M., Nathan, B. M., Liu, S. & Moran, A., 2025, (Accepted/In press) In: Diabetes Technology and Therapeutics.Research output: Contribution to journal › Article › peer-review
-
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
Galderisi, A., Sims, E. K., Evans-Molina, C., Petrelli, A., Cuthbertson, D., Nathan, B. M., Ismail, H. M., Herold, K. C. & Moran, A., Mar 2025, In: Diabetologia. 68, 3, p. 646-661 16 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials
Diabetes TrialNet Study Group, Jun 2024, In: Diabetes care. 47, 6, p. 1048-1055 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: A cases series and literature review
Ahmed, A., Ankireddypalli, A., Harindhanavudhi, T., Moran, A. & Moheet, A., Dec 2024, In: Journal of Clinical and Translational Endocrinology. 38, 100375.Research output: Contribution to journal › Review article › peer-review
Open Access